Source: Virtual Congress 2021 – COVID-19 and management of lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
A. Creamer (London, United Kingdom), J. Dickson (London, United Kingdom), C. Horst (London, United Kingdom), S. Tisi (London, United Kingdom), H. Hall (London, United Kingdom), P. Verghese (London, United Kingdom), J. Mccabe (London, United Kingdom), K. Gyertson (London, United Kingdom), A. Mullin (London, United Kingdom), L. Farrelly (London, United Kingdom), C. Clark (Menlo Park, United States of America), S. Hamilton (Menlo Park, United States of America), B. Allen (Menlo Park, United States of America), A. Hackshaw (London, United Kingdom), A. Devaraj (London, United Kingdom), A. Nair (London, United Kingdom), S. Janes (London, United Kingdom). Delayed interval scanning is not associated with stage-shift at diagnosis: Preliminary results to support guidelines for lung cancer screening during the COVID-19 pandemic. 3844

Member's Comments

No comment yet.

Related content which might interest you: Management of lung cancer screening and incidental findings as well as their integration in existing lung cancer care Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 Close surveillance strategy for early lung cancer: results of 15 years of observation Source: Annual Congress 2008 - New trends in interventional pulmonology Year: 2008 Improving lung cancer diagnosis by combining exhaled-breath data and clinical parameters Source: ERJ Open Res, 6 (1) 00221-2019; 10.1183/23120541.00221-2019 Year: 2020 The efficacy of COPD detection by using a community-based annual screening program for lung cancer Source: Annual Congress 2012 - Methodology in epidemiologic research Year: 2012 The Covid-19 pandemic and lung cancer: psychological and diagnosis impacts Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021 Combining exhaled-breath analysis data with clinical parameters to improve the diagnosis of lung cancer Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer Year: 2019 In lung cancer screening by CT incidental findings are frequent and often of clinical importance Source: Annual Congress 2011 - Epidemiology of lung cancer and screening Year: 2011 Avoiding overdiagnosis in lung cancer screening: the volume doubling time strategy Source: Eur Respir J 2013; 42: 1459-1463 Year: 2013 Early detection of lung cancer – the NELSON trial results into real-life practice Source: ERS webinars 2019 - Early detection of lung cancer – the NELSON trial results into real-life practice Year: 2019 Epidemiological data and correlation with bronchoscopic findings in first diagnosis of lung cancer in the last 3 years in a tertiary Greek hospital Source: Annual Congress 2012 - Epidemiology and care research of lung cancer Year: 2012 The role of bronchoscopy in the diagnosis of lung cancer: an audit to assess standards Source: Eur Respir J 2001; 18: Suppl. 33, 62s Year: 2001 The evidence on CT: lung cancer screening Source: ERS Research Seminar 2018 – Lung Cancer Screening: from Trial to Practice Year: 2018 Quality of life in lung cancer patients: preliminary results of a multi-professional interview for diagnosis disclosure (MIDD) Source: Eur Respir J 2005; 26: Suppl. 49, 459s Year: 2005 Factors determining early adherence to a lung cancer screening protocol Source: Eur Respir J 2007; 30: 532-537 Year: 2007 Early detection of COPD is important for lung cancer surveillance Source: Eur Respir J 2012; 39: 1230-1240 Year: 2012 Cost-effectiveness of biomarker testing for treatment choices in advanced non-small cell lung carcinoma: impact of diagnostic strategies and their turnaround times Source: Eur Respir J, 51 (6) 1800844; 10.1183/13993003.00844-2018 Year: 2018 Cost-effectiveness of biomarker testing for treatment choices in advanced non-small cell lung carcinoma: impact of diagnostic strategies and their turnaround times Source: Eur Respir J, 51 (6) 1800602; 10.1183/13993003.00602-2018 Year: 2018 Fluorescence bronchoscopy (FB) to detect the early lung cancer developement in high-risk aysmptomatic individuals - a pilot study initial results Source: Eur Respir J 2001; 18: Suppl. 33, 63s Year: 2001 An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Year: 2006